Pharma execs talk digital therapeutic pricing. Germany reimburses first two prescribable apps.
10.09.20
7 min. read
Proteus founders explain. Investors talk DTx.
10.02.20
8 min. read
Apple eyes asthma, sleep apnea SaMDs? Amwell-Teladongo suit.
9.18.20
8 min. read
32 Pear patents. Amwell $644M IPO.
9.11.20
6 min. read
New Teladongo merger details. Pear’s acquisitive study strategy.
9.04.20
8 min. read
Will Amazon ruin voice biomarkers? Amwell S-1 insights.
8.28.20
8 min. read
20 percent of Rx-only digital therapeutics have studies so far.
8.14.20
9 min. read
Nine thoughts on Teladongo. CPT sneak peek.
8.07.20
8 min. read
Hinge plans virtual MSK clinic. Livongo upping focus on DPP?
7.31.20
5 min. read
Livongo’s IPO anniversary. DTx pipelines.
7.24.20
7 min. read
1 of 8